Balans kapitallashuviga qarzlar: Adlai Nortye Ltd (ANL)

Adlai Nortye (ANL) korporativ emblemasi va logotipi

Adlai Nortye Ltd. buparlisib dori vositasidan foydalangan holda, rivojlangan saraton bilan kurashishning aniq usullarini ishlab chiqadi. Umumiy qarzdorlikning kapitalga nisbati qarzdorlik yukini vizuallashtiradi, bunda 0.13 qiymati eng so'nggi raqamni ifodalaydi. Yagona nomzodga bog'liqlik va geosiyosiy to'siqlar fonida G'arb ishtirokchilari bilan global raqobat tufayli xatarlar ortib bormoqda.

ANL Adlai Nortye Limited: Qarzning sof aktivlarga nisbati 21.02.2024 - 29.10.2026 oraligʻida

adlainortye.com (ANL) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya narxi Adlai Nortye|ANL - Konsensus maqsadli narx
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Bozor kapitallashuvi Adlai Nortye Ltd.|ANL - Korxonaning umumiy qiymati
- emitentning balans qiymati statistikasi:
Bitta aksiya uchun sof aktivlar Adlai Nortye|ANL - Kompaniyaning buxgalteriya qiymati|Kapitallashuvning sof aktivlarga nisbati adlainortye.com|ANL - Aktivlarning umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Adlai Nortye Ltd.|ANL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Adlai Nortye|ANL - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Adlai Nortye Ltd.|ANL - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzlari Adlai Nortye|Tezkor likvidlik koeffitsiyenti adlainortye.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ANL - Sof foyda
Kompaniyaning fundamental tahlili:ANL (Adlai Nortye Limited)
Adlai Nortye Ltd tovar namunasi

Adlai Nortye Ltd. (ANL) Xitoy yurisdiksiyasining murakkabliklari sharoitida onkologik biotexnologiyalarni ishlab chiqmoqda. Ushbu ko'rsatkich moliyaviy leverajni baholash uchun umumiy qarz majburiyatlarini balansdagi kapital bilan solishtiradi. Qarz va kapital nisbatini tahlil qilish orqali investor choraklik buzilishlarsiz haqiqiy kredit yukini aniqlashi mumkin. Leverajni kamaytirish haddan tashqari to'lov risklarini yumshatadi, ammo global klinik sinovlarga investitsiyalarni cheklaydi. Qarz mablag'larining optimal muvozanati rahbariyatning fundamental barqarorligini tasdiqlaydi.

Muhim raqobatchilar

Balans kapitallashuviga qarzlar ONC (BeiGene Ltd)|HALO - Qarzning balans qiymatiga nisbati|Revolution Medicines, Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Ascentage Pharma Group International|CG Oncology Corp (CGON) - Qarzning balans kapitallashuviga nisbati|UroGen Pharma Corp - Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati BCAX|PSNL: Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar ERAS|Qarzning balans qiymatiga nisbati Delcath Systems Inc DCTH|YmAbs - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Aura Corp AURA|CADL - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati ARAY (accuray.com)|SLS: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Actuate Therapeutics Inc. (ACTU)|CTOR (Citius Oncology, Inc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar TuHURA|Balans kapitallashuviga qarzlar TARA|fatetherapeutics.com - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Aadi Bioscience WHWK|TScan Therapeutics Inc - Qarzning balans kapitallashuviga nisbati|Champions Oncology Corp - Balans kapitallashuviga qarzlar|XBIT - Balans kapitallashuviga qarzlar|CVM: Balans kapitallashuviga qarzlar|OSTX - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati RADX|ARTV: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Veru Pharma (VERU)|Tempest Therapeutics Corp - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Xilio Therapeutics XLO|Renovaro Biosciences (RENB) - Balans qiymatiga qarzlar|MURA - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati KAPA (Kairos Pharma Ltd)|OKUR (onkuretherapeutics.com) - Qarzning balans qiymatiga nisbati|GDTC: Qarzning balans kapitaliga nisbati|Qarzning balans qiymatiga nisbati CRIS|Balans qiymatiga qarzlar Apollomics Corp APLM|Balans kapitallashuviga qarzlar THAR|ADVB - Balans qiymatiga qarzlar|Genprex, Inc - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati CLDI|SBFM - Qarzning balans kapitallashuviga nisbati|XBIO: Qarzning balans kapitallashuviga nisbati|SLRX (Salarius Pharmaceuticals, Inc.) - Qarzning balans qiymatiga nisbati|PPBT: Qarzning balans kapitaliga nisbati|AONC (American Oncology Network Inc) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati BGNE (BeiGene Ltd)|Qarzning balans qiymatiga nisbati CKPT (Checkpoint Therapeutics)|Sof aktivlarga qarzlar elevationoncology.com|Balans kapitallashuviga qarzlar ICAD (iCAD)|Balans kapitallashuviga qarzlar Ikena Oncology Inc. IKNA|NTBL - Qarzning balans kapitallashuviga nisbati|VIRX (Viracta Therapeutics) - Qarzning balans qiymatiga nisbati|MorphoSys AG (MOR) - Qarzning balans kapitallashuviga nisbati|NAYA (nayabiosciences.com) - Qarzning balans kapitallashuviga nisbati|AAPGV (Ascentage Pharma) - Balans kapitallashuviga qarzlar